High expression of CDH3 predicts a good prognosis for colon adenocarcinoma patients

Xu,Yidong; Zhao,Jianpei; Dai,Xiaoyu; Xie,Yangyang; Dong,Mingjun

doi:10.3892/etm.2019.7638

High expression of CDH3 predicts a good prognosis for colon adenocarcinoma patients

Authors:
- Yidong Xu
- Jianpei Zhao
- Xiaoyu Dai
- Yangyang Xie
- Mingjun Dong
View Affiliations

Affiliations: Department of Colorectal Surgery, HwaMei Hospital, University of The Chinese Academy of Sciences, Ningbo, Zhejiang 310015, P.R. China
Published online on: June 3, 2019 https://doi.org/10.3892/etm.2019.7638
Pages: 841-847
Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Colon adenocarcinoma (COAD) is one of the most common types of malignancy of the digestive system, and a better understanding of the molecular mechanisms will contribute to an improvement in the quality of life for COAD patients. Cadherin 3 (CDH3), a gene encoding P‑cadherin, is a major component of adherens junctions and is closely associated with the occurrence and development of a variety of tumor types. However, the current knowledge regarding the role of CDH3 in COAD is limited. The present study aimed to identify the relative mRNA and protein expression levels of CDH3 in COAD tissues, and whether CDH3 had any influence on the survival rate of patients with COAD. Analysis of differentially expressed genes using the UALCAN database revealed that CDH3 was significantly upregulated in COAD tissues, and reverse transcription‑quantitative PCR analysis further confirmed that CDH3 was upregulated in 48 COAD tissues compared with that in their paired normal tissues (n=48). Consistent with this, analysis of the Human Protein Atlas database indicated that the expression levels of the CDH3 protein were upregulated in COAD tissues (n=11) compared with those in normal tissues (n=3; P=0.0245). Next, the association between the mRNA levels of CDH3 and the survival rate of the COAD patients was analyzed using the UALCAN database, and the Kaplan‑Meier curves revealed that the CDH3 high expression group (n=69) had a better overall survival compared with that of the CDH3 medium/low expression group (n=210; P=0.037). Furthermore, analysis of clinical data of a cohort from our hospital indicated that the median survival time for COAD patients with high (n=20) and low (n=20) CDH3 levels was 55.5 and 43.5 months, respectively, and there was a significant difference in the survival time between the two groups (P=0.0078). The above results verified that CDH3 was significantly upregulated in the COAD tissues and that high expression of CDH3 predicts a good prognosis for COAD patients.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer Statistics, 2017. 67:7–30. 2017.
2	Wu K, Xu K, Liu K, Huang J, Chen J, Zhang J and Zhang N: Long noncoding RNA BC200 regulates cell growth and invasion in colon cancer. Int J Biochem Cell Biol. 99:219–225. 2018. View Article : Google Scholar : PubMed/NCBI
3	Mody K and Bekaii-Saab T: Clinical trials and progress in metastatic colon cancer. Surg Oncol Clin N Am. 27:349–365. 2018. View Article : Google Scholar : PubMed/NCBI
4	Deng H, Wang JM, Li M, Tang R, Tang K, Su Y, Hou Y and Zhang J: Long non-coding RNAs: New biomarkers for prognosis and diagnosis of colon cancer. Tumour Biol. 39:10104283177063322017. View Article : Google Scholar : PubMed/NCBI
5	Hankey W, Frankel WL and Groden J: Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: Implications for therapeutic targeting. Cancer Metastasis Rev. 37:159–172. 2018. View Article : Google Scholar : PubMed/NCBI
6	Raskov H, Pommergaard HC, Burcharth J and Rosenberg J: cColorectal carcinogenesis-update and perspectives. World J Gastroenterol. 20:18151–18164. 2014. View Article : Google Scholar : PubMed/NCBI
7	Malhotra P, Anwar M, Nanda N, Kochhar R, Wig JD, Vaiphei K and Mahmood S: Alterations in K-ras, APC and p53-multiple genetic pathway in colorectal cancer among Indians. Tumour Biol. 34:1901–1911. 2013. View Article : Google Scholar : PubMed/NCBI
8	Hammoudi A, Song F, Reed KR, Jenkins RE, Meniel VS, Watson AJ, Pritchard DM, Clarke AR and Jenkins JR: Proteomic profiling of a mouse model of acute intestinal Apc deletion leads to identification of potential novel biomarkers of human colorectal cancer (CRC). Biochem Biophys Res Commun. 440:364–370. 2013. View Article : Google Scholar : PubMed/NCBI
9	Jeong D, Heo S, Sung Ahn T, Lee S, Park S, Kim H, Park D, Byung Bae S, Lee SS, Soo Lee M, et al: Cyr61 expression is associated with prognosis in patients with colorectal cancer. BMC Cancer. 14:1642014. View Article : Google Scholar : PubMed/NCBI
10	Li X, Yang C, Wang X, Zhang J, Zhang R and Liu R: The expression of miR-25 is increased in colorectal cancer and is associated with patient prognosis. Med Oncol. 31:7812014. View Article : Google Scholar : PubMed/NCBI
11	Lin PL, Wu DW, Huang CC, He TY, Chou MC, Sheu GT and Lee H: MicroRNA-21 promotes tumour malignancy via increased nuclear translocation of β-catenin and predicts poor outcome in APC-mutated but not in APC-wild-type colorectal cancer. Carcinogenesis. 35:2175–2182. 2014. View Article : Google Scholar : PubMed/NCBI
12	Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D and Slack FJ: RAS is regulated by the let-7 microRNA family. Cell. 120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
13	Hansen TF, Christensen Rd, Andersen RF, Sørensen FB, Johnsson A and Jakobsen A: MicroRNA-126 and epidermal growth factor-like domain 7-an angiogenic couple of importance in metastatic colorectal cancer. Results from the Nordic ACT trial. Br J Cancer. 109:1243–1251. 2013. View Article : Google Scholar : PubMed/NCBI
14	Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B and Varambally S: UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 19:649–658. 2017. View Article : Google Scholar : PubMed/NCBI
15	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
16	Prevostel C and Blache P: The dose-dependent effect of SOX9 and its incidence in colorectal cancer. Eur J Cancer. 86:150–157. 2017. View Article : Google Scholar : PubMed/NCBI
17	Malla RR, Pandrangi S, Kumari S, Gavara MM and Badana AK: Exosomal tetraspanins as regulators of cancer progression and metastasis and novel diagnostic markers. Asia Pac J Clin Oncol. 14:383–391. 2018. View Article : Google Scholar : PubMed/NCBI
18	Kumara HMCS, Bellini GA, Caballero OL, Herath SAC, Su T, Ahmed A, Njoh L, Cekic V and Whelan RL: P-Cadherin (CDH3) is overexpressed in colorectal tumors and has potential as a serum marker for colorectal cancer monitoring. Oncoscience. 4:139–147. 2017.PubMed/NCBI
19	Hibi K, Goto T, Mizukami H, Kitamura YH, Sakuraba K, Sakata M, Saito M, Ishibashi K, Kigawa G, Nemoto H and Sanada Y: Demethylation of the CDH3 gene is frequently detected in advanced colorectal cancer. Anticancer Res. 29:2215–2217. 2009.PubMed/NCBI
20	Hibi K, Kitamura YH, Mizukami H, Goto T, Sakuraba K, Sakata M, Saito M, Ishibashi K, Kigawa G, Nemoto H and Sanada Y: Frequent CDH3 demethylation in advanced gastric carcinoma. Anticancer Res. 29:3945–3947. 2009.PubMed/NCBI
21	Kim TH, Chang JH, Lee HJ, Kim JA, Lim YS, Kim CW and Han SW: mRNA expression of CDH3, IGF2BP3 and BIRC5 in biliary brush cytology specimens is a useful adjunctive tool of cytology for the diagnosis of malignant biliary stricture. Medicine (Baltimore). 95:e41322016. View Article : Google Scholar : PubMed/NCBI
22	Yi S, Yang ZL, Miao X, Zou Q, Li J, Liang L, Zeng G and Chen S: N-cadherin and P-cadherin are biomarkers for invasion, metastasis and poor prognosis of gallbladder carcinomas. Pathol Res Pract. 210:363–368. 2014. View Article : Google Scholar : PubMed/NCBI
23	Yang Z, Ghoorun RA, Fan X, Wu P, Bai Y, Li J, Chen H, Wang L and Wang J: High expression of Beclin-1 predicts favorable prognosis for patients with colorectal cancer. Clin Res Hepatol Gastroenterol. 39:98–106. 2015. View Article : Google Scholar : PubMed/NCBI
24	Bujko M, Kober P, Mikula M, Ligaj M, Ostrowski J and Siedlecki JA: Expression changes of cell-cell adhesion-related genes in colorectal tumors. Oncol Lett. 9:2463–2470. 2015. View Article : Google Scholar : PubMed/NCBI